Measurement properties of the Medical Outcomes Study Sleep Scale in patients with fibromyalgia

Sleep Medicine

Volumn 10, Issue 7, 2009, Pages 766-770

  Cappelleri, Joseph C ^a   Bushmakin, Andrew G ^a   McDermott, Anne M ^b   Dukes, Ellen ^c   Sadosky, Alesia ^c   Petrie, Charles D ^a   Martin, Susan ^c  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^b Global Outcomes Research ^*  (United States)

^c PFIZER INC   (United States)

Author keywords

Fibromyalgia; Insomnia; Medical Outcomes Study; MOS Sleep Scale; Sleep problems

Indexed keywords

PLACEBO; PREGABALIN;

ADULT; AGE DISTRIBUTION; ARTICLE; CAUCASIAN; CLINICAL TRIAL; CONTROLLED STUDY; CRONBACH ALPHA COEFFICIENT; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; FACTORIAL ANALYSIS; FEMALE; FIBROMYALGIA; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICAL OUTCOMES STUDY SLEEP SCALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SLEEP DISORDER; STATISTICAL ANALYSIS; SYMPTOM;

DISORDERS OF EXCESSIVE SOMNOLENCE; FACTOR ANALYSIS, STATISTICAL; FATIGUE; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SLEEP DEPRIVATION; WAKEFULNESS;

EID: 62749104064     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2008.09.004     Document Type: Article

References (30)

1. Wolfe F., Smythe H.A., Yunus M.B., et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33 (1990) 160-172
2. Wolfe F. The epidemiology of fibromyalgia. J Musculoskeletal Pain 1 (1993) 137-148
3. Wolfe F., Ross K., Anderson J., et al. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38 (1995) 19-28
4. Mease P., Arnold L.M., Bennett R., et al. Fibromyalgia syndrome. J Rheumatol 34 (2007) 1415-1425
5. Bennett R.M., Jones J., Turk D.C., and Matallana L. An internet survey of 2596 people with fibromyalgia. BMC Musculoskelet Disord 8 (2007) 27
6. Hays R., and Stewart A. Sleep measures. In: Stewart A., and Ware J. (Eds). Measuring functioning and well-being approach: the medical outcomes study (1992), Duke University Press, Durham, NC pp. 235-259
7. Hays R.D., Martin S.A., Sesti A.M., and Spritzer K.L. Psychometric properties of the Medical Outcomes Study Sleep measure. Sleep Med 6 (2005) 41-44
8. Rejas J., Ribera M.V., Ruiz M., and Masrramon X. Psychometric properties of the MOS (Medical Outcomes Study) Sleep Scale in patients with neuropathic pain. Eur J Pain 11 (2007) 329-340
9. Wolfe F., Michaud K., and Li T. Sleep disturbance in patients with rheumatoid arthritis: evaluation by medical outcomes study and visual analog sleep scales. J Rheumatol 33 (2006) 1942-1951
10. L.M. Arnold, I.J. Russell, E.W. Diri et al. A 14-week, randomized, double-blind, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain (2008). Available online at www.sciencedirect.com.
11. Mease P.J., Russell I.J., Arnold L.M., et al. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol 35 (2008) 502-514
12. Melzack R. The short-form McGill Pain Questionnaire. Pain 30 (1987) 191-197
13. Food and Drug Administration. Guidance for Industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. [Draft]. 2006. Available at: http://www.fda.gov/cder/guidance/5460dft.htm. Accessed January 6, 2008.
14. ® system for factor analysis and structural equation modeling (1994), SAS Institute Inc., Cary, NC
15. Stevens J. Applied Multivariate Statistics for the Social Sciences (2002), Lawrence Erlbaum, Mahwah, NJ
16. Ware J. Methodological considerations in the selection of health status assessment procedures. In: Wenger N., Mattson M., Furberg C., and Elinson J. (Eds). Assessment of quality of life in clinical trials of cardiovascular therapies (1984), Le Jacq Publishing Inc., New York pp. 87-111
17. Nunnally J.C., and Bernstein I.H. Psychometric theory (1994), McGraw-Hill, New York
18. Fitzmaurice G., Laird N., and Ware J. Applied Longitudinal Analysis (2004), John Wiley & Sons, New York
19. Guyatt G.H., Osoba D., Wu A.W., et al. Methods to explain the clinical significance of health status measures. Mayo Clin Proc 77 (2002) 371-383
20. Crosby R.D., Kolotkin R.L., and Williams R. Defining clinically meaningful change in health-related quality life. J Clin Epidemiol 56 (2003) 395-407
21. Farrar J.T., Young Jr. J.P., LaMoreaux L., et al. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94 (2001) 149-158
22. Dworkin R.H., Turk D.C., Wyrwich K.W., et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 9 (2008) 105-121
23. Bollen K., and Lennox R. Conventional wisdom on measurement: a structural equation perspective. Psychometric Bull 110 (1991) 305-314
24. Abad V., Sarinas P., and Guilleminault C. Sleep and rheumatologic disorders. Sleep Med Rev 12 (2008) 211-228
25. ™ 4.0 Generic Core Scales. Health Qual Life Outcomes 5 (2007) 43
26. Eichling P., and Sahni J. Menopause related sleep disorders. J Clin Sleep Med 1 (2005) 291-300
27. Annemans L., Wessely S., Spaepen E., et al. Health economic consequences related to the diagnosis of fibromyalgia syndrome. Arthritis Rheum 58 (2008) 895-902
28. Delgado J., Murali G., and Goldberg R. Sleep disorders in fibromyalgia. Sleep 27 (2004) A339
29. Khan S., Goldberg R., and Haber A. Sleep disorders in fibromyalgia. Sleep 28 (2005) A290
30. Ware J.E., Kosinski M., and Dewey J.E. How to score version 2 of the SF-36 (r) health survey (2000), Quality Metric, Lincoln, RI